Integer reports Q4 adjusted EPS $1.76, 23% YoY growth; full year adjusted EPS $6.40, up 21%

Integer Holdings Corp

2025-FY EPS reported $2.89 revenue$1,853,637,000

Q4 sales $472M (+5% YoY); GAAP EPS $1.38, adjusted EPS $1.76 (+23%).
FY25 sales $1.854B (+8%); GAAP EPS $2.89 (-15%), adjusted EPS $6.40 (+21%).
Cardio & Vascular sales grew 11% Q4; Cardiac Rhythm Mgmt & Neuromodulation down 2% Q4.
Initiates $50M accelerated share repurchase under existing $200M board authorization.
2026 outlook: sales $1.826B-$1.876B (flat YoY); adjusted EPS $6.29-$6.78 (down 2% to up 6%).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.